24 May 2013
Keywords: approval, novartis, generic, betaferon, eu, swiss, drug
Article | 02 June 2008
Swiss drug major Novartis has received approval from the European Commission for Extavia (interferon beta-1b), its generic version of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 June 2008
9 June 2008
23 May 2013
© 2013 thepharmaletter.com